AKT1 (E17K) mutation in pancreatic cancer.

AKT1 (E17K) mutation in pancreatic cancer.

Item
http://www.wikidata.org/entity/Q39941342
Cancer associated E17K mutation causes rapid conformational drift in AKT1 pleckstrin homology (PH) domainPro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.Regulation of Akt signaling activation by ubiquitination.Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma.K63-linked ubiquitination in kinase activation and cancer.Mutant AKT1-E17K is oncogenic in lung epithelial cellsThe oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas.Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.Metabolism addiction in pancreatic cancer.Differential effects of AKT1(p.E17K) expression on human mammary luminal epithelial and myoepithelial cells.Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cells.
P2860

AKT1 (E17K) mutation in pancreatic cancer.

Item
http://www.wikidata.org/entity/Q39941342
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
AKT1 (E17K) mutation in pancreatic cancer.
@en
AKT1
@nl
type
label
AKT1 (E17K) mutation in pancreatic cancer.
@en
AKT1
@nl
prefLabel
AKT1 (E17K) mutation in pancreatic cancer.
@en
AKT1
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
AKT1 (E17K) mutation in pancreatic cancer.
@en
P2093
P2860
P304
P31
P356
10.1177/153303460800700509
P433
P478
P577
P698